Harrow Health, Inc. (HROW) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. on November 17, 2020. The report serves as a disclosure under Regulation FD (Item 7.01) regarding a corporate presentation used by management at investor conferences and meetings.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a cover for an attached presentation (Exhibit 99.1) rather than containing detailed financial statements itself.
Material Changes
No material changes to financial performance or operations are detailed within the text of this specific filing. The report focuses solely on the dissemination of the attached corporate presentation.
Guidance, Outlook, and Risks
Management commentary and outlook are contained within the attached Exhibit 99.1 (Corporate Presentation dated November 2020). The filing explicitly states that the information in Item 7.01 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless specifically referenced.
Key Facts for Investor Verification
- Verify the contents of Exhibit 99.1 for actual financial data, guidance, and strategic updates, as the 8-K text only references this attachment.
- Note that the presentation materials are not legally "filed" under Section 18 of the Exchange Act, limiting liability for forward-looking statements contained therein.
- Confirm the company's status as a Delaware corporation with principal offices in Nashville, Tennessee.